Ribavirin as therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

Annals of Internal Medicine

Volumn 123, Issue 12, 1995, Pages 897-903

  Di Bisceglie, A M ^a   Conjeevaram, H S ^a   Fried, M W ^a   Sallie, R ^a   Park, Y ^a   Yurdaydin, C ^a   Swain, M ^a   Kleiner, D E ^a   Mahaney, K ^a   Hoofnagle, J H ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RIBAVIRIN; VIRUS RNA;

ADULT; AGED; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HEPATITIS C; HUMAN; HUMAN TISSUE; LIVER BIOPSY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0028825313     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-123-12-199512150-00001     Document Type: Article

References (0)